stopped semaglutide for a month The Ozempic Rebound: What the Data Actually Shows 📉💊 The clinical data is clear: stopping GLP-1 medications without structured exit strategy often leads to rapid weight regain within 12 months. But 1 Month On Semaglutide :

Supraclavicular lymphadenopathy (above the collarbone) requires urgent assessment

While their clinical use is supported by an expanding body of research in functional and regenerative medicine, they are not FDA-approved for all indications

The worst outcome is when weight loss gets treated as the solution to a problem thats actually anatomic

The Legal Arguments Plaintiffs Claim: Manufacturers (Novo Nordisk, Eli Lilly) knew or should have known about risks of gastroparesis and NAION Warning labels failed to adequately disclose these serious side effects Drugs were aggressively marketed as safe and effective weight loss solutions without proper risk disclosure Patients would not have taken the medications had they known the true risks Defendants Respond: Claims are unfounded (Novo Nordisk statement) Will defend vigorously against lawsuits Motion to dismiss expected January 24, 2025 Argue that labels were adequate and that many conditions may be pre-existing or related to diabetes itself Whos Most at Risk